Vincent Badalamenti Email

Associate VP Pharmacovigilance . Reata Pharmaceuticals

Current Roles

Employees:
417
Revenue:
$53.6M
About
Reata Pharmaceuticals, Inc. (Nasdaq:RETA) is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation. Reata's two most advanced clinical candidates, bardoxolone methyl and omaveloxolone, target the important transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation.
Reata Pharmaceuticals Address
5320 Legacy Dr
Irving, TX
United States
Reata Pharmaceuticals Email

Past Companies

Reata Pharmaceuticals, Inc.Associate Vice President Pharmacovigilance
UCBDirector & Global Safety Lead, Patient Safety Unit Neurology
UCBDirector, Head of Surveillance Management

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.